Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales
about
Modelling the time-dependent transmission rate for porcine circovirus type 2 (PCV2) in pigs using data from serial transmission experiments.Estimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on reception into prison.Regional differences in HIV prevalence among drug users in China: potential for future spread of HIV?A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design.The hepatitis C cascade of care: identifying priorities to improve clinical outcomesHigh-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs.Controversies in and challenges to our understanding of hepatitis C.Dynamics of the force of infection: insights from Echinococcus multilocularis infection in foxes.Characteristics of HIV-infected women and factors associated with HCV seropositivity in the Republic of Georgia.The Hidden Burden of Dengue and Chikungunya in Chennai, IndiaThe need for treatment scale-up to impact HCV transmission in people who inject drugs in Montréal, Canada: a modelling study.Modelling the prevalence of hepatitis C virus amongst blood donors in Libya: An investigation of providing a preventive strategy.New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in EnglandPrisons and HCV: a review and a report on an experience in New South Wales Australia.An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence.Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review.Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.Visual versus written cues: a comparison of drug injectors' responses. Have surveys using the written word underestimated risk behaviors for hepatitis C?Hepatitis C infection among injection drug users in Stockholm Sweden: prevalence and gender.Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs.Increasing incidence of zoonotic visceral leishmaniasis on Crete, Greece.Exploration of genetically determined resistance against hepatitis C infection in high-risk injecting drug users.Estimating the variability in the risk of infection for hepatitis C in the Glasgow injecting drug user population.Prevalence and correlates of needle-sharing among new and long-term injection drug users in southwest China.A time since onset of injection model for hepatitis C spread amongst injecting drug users.Estimating the prevalence of ex-injecting drug use in the population.Modelling alternative strategies for delivering hepatitis B vaccine in prisons: the impact on the vaccination coverage of the injecting drug user population.The incidence of hepatitis E virus infection in the general population of the USA.DC-SIGN Polymorphisms Associated with Risk of Hepatitis C Virus Infection Among Men who Have Sex with Men but not Among Injecting Drug Users.Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004.Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?Prevalence and incidence of hepatitis C in injecting drug users attending genitourinary medicine clinics.Modeling of Hepatitis B Epidemic Process by the Risk Factors Analysis.Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets?Trust, disruption and responsibility in accounts of injecting equipment sharing and hepatitis C risk
P2860
Q31159468-E762B47A-C0CE-4D9B-980C-5FB96A4F6FD0Q33248072-DC2AE754-FE5F-4138-8BFB-44606C52CF59Q33357698-75CFA9C2-C993-4D0C-98C3-AB540A8CB638Q33483115-CFB9879B-2688-45CB-805E-07565000D43CQ33632459-51BF5A84-A43C-4DB7-8F00-14A10FC4D6B1Q34079048-242DB691-0319-47C0-ABD2-0629C3AAEE60Q34604806-AB4D5947-E7AB-47DF-8A41-B937DE2EDDD6Q35126544-EEE60315-D45A-4BAC-AD86-FB88AB0536ADQ35158311-3733D0B7-9297-4581-96F4-5537F97B39E5Q35858397-7137FFFF-DBC5-4AB9-989E-1290DEB77197Q36286654-9B30E8F8-5753-4635-845B-C909C91E9071Q36527644-9E82B877-3792-4285-BDA8-FDAF463957DAQ37169457-D25F563E-484C-43B7-B6FA-AB66A16AE3C9Q37242489-56BEEA63-F4A4-45F0-AC5C-5FA6CA632F79Q37696544-31A7B1E6-31A5-4219-A7DA-F327039D3278Q38255693-8E02DC47-9FA1-423F-BAF3-C7A39A858138Q39559479-5856FD46-D3F9-4C32-8FE7-C65630C6AA6AQ39877075-ABBE1AD8-F4E9-4E42-8572-266B629BDA43Q39971560-3716EFF0-72E6-4224-A054-E9BE37B6628BQ40989823-203AC527-7795-4945-8FAC-A1ADAAEA6D07Q41870741-DD915AFA-2DCF-489F-BA4B-2AE1782CDD19Q42232714-D0A73B43-1A79-4D87-962E-EC77B3ED09FAQ42642021-6AA631F8-9E16-4534-808D-3E1E91D5A52CQ42663450-FAD5C785-71ED-4D33-ABEB-3C505B9C0265Q42983662-BE623322-CDC6-4954-9DFF-CC22A79233E1Q43428423-9EC683A3-5E7C-48B8-883B-D6741AD7061DQ45103719-EF7DBBA2-A9E3-4B69-9799-9174D44D93DDQ45185642-703A1D22-936B-434E-952C-D9D906A49708Q45324822-84274DD9-4980-4D08-9826-83D72E869547Q45401216-26BFFF5F-CD4E-46D5-B91F-3D6E15EC684BQ47573617-4C2EF4D8-7702-4AEF-B875-F1E7FE611796Q51126531-F30B4C07-64C8-4F57-B9AE-A84366719F59Q55559486-BF9883E8-4E49-41A6-B09B-4E1A381C4CF5Q57700826-73624DEB-1134-44A0-8AA9-442B79BF7F7AQ57773664-C85448DD-8EFE-499A-AF03-4D3201A0D2F1
P2860
Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Modelling the force of infecti ...... rug users in England and Wales
@ast
Modelling the force of infecti ...... rug users in England and Wales
@en
Modelling the force of infecti ...... rug users in England and Wales
@nl
type
label
Modelling the force of infecti ...... rug users in England and Wales
@ast
Modelling the force of infecti ...... rug users in England and Wales
@en
Modelling the force of infecti ...... rug users in England and Wales
@nl
prefLabel
Modelling the force of infecti ...... rug users in England and Wales
@ast
Modelling the force of infecti ...... rug users in England and Wales
@en
Modelling the force of infecti ...... rug users in England and Wales
@nl
P2093
P2860
P3181
P356
P1476
Modelling the force of infecti ...... rug users in England and Wales
@en
P2093
P2860
P2888
P3181
P356
10.1186/1471-2334-6-93
P407
P5530
P577
2006-06-08T00:00:00Z
P5875
P6179
1011918873